BIOLASE (BIOL) Trading 8.2% Higher

BIOLASE Inc (NASDAQ:BIOL)’s share price traded up 8.2% on Thursday . The company traded as high as $0.56 and last traded at $0.53. 654,797 shares traded hands during trading, an increase of 144% from the average session volume of 268,102 shares. The stock had previously closed at $0.49.

Separately, ValuEngine raised BIOLASE from a “sell” rating to a “hold” rating in a research report on Monday, October 2nd.

The stock has a market capitalization of $40.28, a PE ratio of -1.61 and a beta of 2.32.

In other news, major shareholder Larry N. Feinberg purchased 12,545,615 shares of BIOLASE stock in a transaction on Tuesday, December 5th. The stock was purchased at an average price of $0.43 per share, with a total value of $5,394,614.45. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 7.10% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Markets Daily and is the sole property of of Markets Daily. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at


BIOLASE, Inc (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers.

Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply